[VYNE] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
14-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 17.95%
YoY- 32.92%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 114 135 99 6 167 126 178 -25.67%
PBT -6,071 -10,038 -5,612 -7,748 -9,255 -8,235 -8,694 -21.27%
Tax 513 20 10 13 204 241 -13,364 -
NP -6,584 -10,058 -5,622 -7,761 -9,459 -8,476 4,670 -
Tax Rate - - - - - - - -
Total Cost 6,698 10,193 5,721 7,767 9,626 8,602 -4,492 -
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -5,775.44 -7,450.37 -5,678.79 -129,350.00 -5,664.07 -6,726.98 2,623.60 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -2.01 -3.08 -1.72 -2.60 -2.94 -2.63 1.52 -
EPS Diluted -2.01 -3.08 -1.72 -2.60 -2.94 -2.63 1.52 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.